Zuul is a modern hybrid-indica strain whose exact origins remain undocumented. Breeders have not publicly confirmed a comprehensive genetic history, and while the strain is noted to be derived from Fall 97, the full lineage is considered incomplete and lacks a widely accepted narrative or breeder source. Growing this variety requires moderate cultivation skill, but it remains accessible for both indoor and outdoor environments. Growers can expect a high yield from this plant, which reaches maturity after a 65-day flowering cycle.

The terpene profile of Zuul is explicitly confirmed, moving from caryophyllene as the dominant compound, followed by myrcene, limonene, humulene, linalool, bisabolol, nerolidol, beta-pinene, pinene, geraniol, borneol, camphene, terpinolene, and caryophyllene-oxide. This broad spectrum of compounds creates a complex sensory experience defined by its specific sequence of volatile oils. As a THC-dominant cultivar, it contains an estimated 17.7% THC alongside an estimated 0.05% CBD, providing a chemical composition that anchors its objective cannabinoid profile.

Users of Zuul report an experience characterized by feelings of relaxation and focused awareness. These effects make the strain a functional choice for addressing pain, stress, and sleep concerns. While the plant maintains a consistent profile in its chemistry and growth habits, there are currently no recorded offspring linked to this variety in the genetic record.